<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7318922\results\search\drug\results.xml">
  <result pre="Drugs used to treat COVID suspected of causing exanthems are" exact="hydroxychloroquine" post="(morbilliform) and azithromycin (morbilliform, urticarial) Young and Fernandez, 2020"/>
  <result pre="treat COVID suspected of causing exanthems are hydroxychloroquine (morbilliform) and" exact="azithromycin" post="(morbilliform, urticarial) Young and Fernandez, 2020 High variability is"/>
  <result pre="to protect against infection and spread (Schmitt, 2020). Avoidance of" exact="ibuprofen" post="and other nonsteroidal anti-inflammatory drugs (NSAIDs) has been suggested"/>
  <result pre="(FitzGerald, 2020, Giollo et al., 2020). Switching from NSAIDs to" exact="acetaminophen" post="is a reasonable alternative in healthy individuals who require"/>
  <result pre="workplace areas are recommended to be frequently disinfected using 75%" exact="alcohol" post="products or disinfecting wipes. Examples of places to clean"/>
  <result pre="seconds or using a hand sanitizer with at least 60%" exact="alcohol" post="Avoid touching your eyes, nose, and mouth Cover your"/>
  <result pre="et al., 2006). That said, a new clinical trial of" exact="methylprednisolone" post="has recently been approved to determine whether COVID-19 cases"/>
  <result pre="of antiviral medications to help suppress viral replication, and both" exact="ritonavir" post="and lopinavir are being studied in clinical trials (Shionogi,"/>
  <result pre="medications to help suppress viral replication, and both ritonavir and" exact="lopinavir" post="are being studied in clinical trials (Shionogi, Toyama Chemical;"/>
  <result pre="SARS epidemic (Chu et al., 2004). Remdesivir (Gilead Pharmaceuticals Inc," exact="Foster" post="City, CA) is an investigational drug that was considered"/>
  <result pre="cascade (Tang et al., 2012). A nonrandomized clinical trial combining" exact="azithromycin" post="and hydroxychloroquine initially showed promising therapeutic potential (Gautret et"/>
  <result pre="et al., 2012). A nonrandomized clinical trial combining azithromycin and" exact="hydroxychloroquine" post="initially showed promising therapeutic potential (Gautret et al., 2020)."/>
  <result pre="the combination of drugs can potentiate cardiac arrythmias. Most recently," exact="hydroxychloroquine" post="has fallen out of favor as a therapy of"/>
  <result pre="benefit, followed by the retraction of a Lancet article supporting" exact="hydroxychloroquine" post="(Chorin et al., 2020, Mehra et al., 2020). Additionally,"/>
  <result pre="CuiY.SongY.Genome and evolution of yersinia pestisAdv Exp Med Biol918201617119227722863 DayM.Covid-19:" exact="Ibuprofen" post="should not be used for managing symptoms, say doctors"/>
  <result pre="study in Spain with 375 casesBr J Dermatol18312020717732348545 GautretP.LagierJ.C.ParolaP.HoangV.T.MeddebL.MailheM.Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: results of an open-label"/>
  <result pre="livedo reticularisJ Am Acad DermatolS0190â€&quot;96222020203055830562 McEvedyC.The bubonic plagueSci Am258219881181233055286 MehraM.R.DesaiS.S.RuschitzkaF.PatelA.N.Retracted:" exact="Hydroxychloroquine" post="or chloroquine with or without a macrolide for treatment"/>
  <result pre="Am Acad DermatolS0190â€&quot;96222020203055830562 McEvedyC.The bubonic plagueSci Am258219881181233055286 MehraM.R.DesaiS.S.RuschitzkaF.PatelA.N.Retracted: Hydroxychloroquine or" exact="chloroquine" post="with or without a macrolide for treatment of COVID-19:"/>
  <result pre="Pediatric 2020 [Epub ahead of publication]. SchrezenmeierE.DÃ¶rnerT.Mechanisms of action of" exact="hydroxychloroquine" post="and chloroquine: implications for rheumatologyNat Rev Rheumatol16202015516632034323 SchwartzD.A.GrahamA.L.Potential maternal"/>
 </snippets>
</snippetsTree>
